IFNG and hepatocellular carcinoma: In this study, we investigated the involvement of IDO1 and its downstream pathway in HCC by implementing interferon-γ (IFN-γ)-modulated IDO1-inducible models in control and IDO1 knockdown HCC and normal hepatic cells as a comparison.